{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"BioVie Inc."},"Symbol":{"label":"Symbol","value":"BIVI"},"Address":{"label":"Address","value":"2120 COLORADO AVENUE,SUITE 230 SUITE 204, SANTA MONICA, Nevada, 90404, United States"},"Phone":{"label":"Phone","value":"+1 312 283-5793"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism."},"CompanyUrl":{"label":"Company Url","value":"https://www.bioviepharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cuong Viet Do","title":"President, Chief Executive Officer & Director"},{"name":"Joseph M. Palumbo","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}